PGR and breast cancer: Similarly, 59 of 72 (81.9%) progesterone receptor (PR)-negative paraffin-embedded breast cancer tissues displayed moderate or strong nuclear NSUN2 staining, whereas 49 of 119 (41.2%) PR-positive tumor samples showed a decrease in NSUN2 staining (P=0.001).